MOTS-c research evidence and limitations
What is MOTS-c?
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-amino-acid peptide encoded within the mitochondrial genome. Lee and colleagues described it in 2015 as part of a broader class of mitochondrial-derived peptides under investigation in metabolism research. Unlike peptides encoded by nuclear DNA, MOTS-c arises from a short open reading frame inside the 12S ribosomal RNA region of mitochondrial DNA, which makes it a distinctive research subject.
This article summarizes the published research record for MOTS-c together with its limitations. It is written for qualified laboratory professionals evaluating the MOTS C 10MG listing referenced by this site as a research subject. It is not a treatment guide and does not provide medical advice.
Reported laboratory findings
The 2015 Cell Metabolism paper reported that MOTS-c levels responded to metabolic stress in cell culture, and the authors observed effects on glucose metabolism and insulin sensitivity in mouse models. The same paper described changes in body weight and adipose tissue in mice fed a high-fat diet. These observations established MOTS-c as a research tool for studying mitochondrial signaling, not as a validated intervention of any kind.
A 2018 study in Cell Metabolism examined how the peptide behaves under metabolic stress. The researchers reported that MOTS-c translocates to the cell nucleus, where it interacted with antioxidant-response elements and influenced nuclear gene expression in their models. This work framed MOTS-c as a retrograde signal from mitochondria to the nucleus.
In 2021, a Nature Communications paper examined MOTS-c as an exercise-induced signal. The authors reported age-related differences in circulating MOTS-c within small human cohorts, and they observed effects on physical capacity measures in aged mice in their experiments. A 2022 review in Aging and Disease summarized the emerging MOTS-c literature and emphasized how preliminary much of the human evidence remains.
Limitations of the current evidence
- Most findings come from cell culture and rodent models. Results in model systems do not establish equivalent effects in humans.
- Human data remain limited to small observational cohorts and short experimental series; controlled human clinical evidence is not established.
- Long-term significance, behavior in diverse tissues, and reproducibility across independent laboratories remain uncertain.
- Published studies do not establish that any supplier material matches the identity, purity, or handling conditions used in any given experiment.
- Research findings cannot establish clinical benefit in humans, and MOTS-c is not approved for human or veterinary use.
Context for research sourcing
The supplier listing referenced by this site is MOTS C 10MG, supplied as research material. Analytical documentation such as a certificate of analysis addresses the identity and purity of a specific lot; it does not reproduce the conditions of any published experiment. Laboratories evaluating this material should review the site research-use-only policy and the references below, and should confirm lot-specific documentation with the supplier before planning experiments.
References
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. PubMed 25738459
- Kim KH, Son JM, Benayoun BA, Lee C. The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metab. 2018;28(3):516-524. PubMed 29983250
- Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12:470. PubMed 33473109
- Mohtashami Z, Singh MK, Salimiaghdam N, Ozgul M, Kenney MC. MOTS-c, the most recent mitochondrial derived peptide in human aging and age-related diseases. Aging Dis. 2022;13(5):1396-1404. PubMed 36186148
For research use only. Not for human or veterinary use. No therapeutic claims are made. Research findings do not establish safety or efficacy for human or veterinary use.